Evidence map›Paper›PMID 34716922›Full record

ArticleJournal of neurochemistry2021

Influence of basal media composition on barrier fidelity within human pluripotent stem cell-derived blood-brain barrier models.

Emma H Neal, Ketaki A Katdare, Yajuan Shi, Nicholas A Marinelli, Kameron A Hagerla, Ethan S Lippmann

Abstract read
In one paragraph

Article in Journal of neurochemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Effects of Propofol on a HumanFrontiers in cellular neuroscience · 2022
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emma H NealDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee, USA.
Ketaki A KatdareVanderbilt Brain Institute, Vanderbilt University, Nashville, Tennessee, USA.ORCID 0000-0001-9345-7592
Yajuan ShiDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee, USA.
Nicholas A MarinelliChemical and Physical Biology Program, Vanderbilt University, Nashville, Tennessee, USA.
Kameron A HagerlaVanderbilt Brain Institute, Vanderbilt University, Nashville, Tennessee, USA.
Ethan S LippmannDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee, USA.ORCID 0000-0001-5703-5747

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STACIE B DUSETZINA · 1995 to 2026
$172.8M
Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALVIN C POWERS · 2012 to 2026
$29.3M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI David J. Calkins · 1989 to 2026
$19.6M
Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at VanderbiltP50HD103537 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jeffrey L Neul · 2020 to 2026
$10.3M
VANTAGE:Consolidation to create the Vanderbilt Technologies for Advanced GenomicsG20RR030956 · NCRR · VANDERBILT UNIVERSITY · PI PIETENPOL, JENNIFER A · 2010 to 2010
$8.7M
Integrated Training in Engineering and DiabetesT32DK101003 · NIDDK · VANDERBILT UNIVERSITY · PI Jamey D. Young · 2014 to 2026
$3.9M
iPSC-derived Neurovascular OrganoidsR01NS110665 · NINDS · VANDERBILT UNIVERSITY · PI LIPPMANN, ETHAN · 2020 to 2024
$2.5M
iPSC-derived neurovascular tissue model of cerebral amyloiad angiopathyR61NS112445 · NINDS · VANDERBILT UNIVERSITY · PI LIPPMANN, ETHAN · 2020 to 2020
$832k
Elucidating Novel Human Blood-Brain Barrier ComponentsR21NS106510 · NINDS · VANDERBILT UNIVERSITY · PI LIPPMANN, ETHAN · 2018 to 2019
$432k
NCATS NIH HHS UL1 TR002243NCI NIH HHS P30 CA068485NCRR NIH HHS G20 RR030956NCRR NIH HHS UL1 RR024975NEI NIH HHS P30 EY008126NICHD NIH HHS P50 HD103537NIDDK NIH HHS P30 DK020593NIDDK NIH HHS T32 DK101003NINDS NIH HHS R01 NS110665NINDS NIH HHS R21 NS106510NINDS NIH HHS R61 NS112445
6 · The paper itself

Abstract

It is increasingly recognized that brain microvascular endothelial cells (BMECs), the principal component of the blood-brain barrier (BBB), are highly sensitive to soluble cues from both the bloodstream and the brain. This concept extends in vitro, where the extracellular milieu can also influence BBB properties in cultured cells. However, the extent to which baseline culture conditions can affect BBB properties in vitro remains unclear, which has implications for model variability and reproducibility, as well as downstream assessments of molecular transport and disease phenotypes. Here, we explore this concept by examining BBB properties within human-induced pluripotent stem cell (iPSC)-derived BMEC-like cells cultured under serum-free conditions in DMEM/F12 and Neurobasal media, which have fully defined compositions. We demonstrate notable differences in both passive and active BBB properties as a function of basal media composition. Further, RNA sequencing and phosphoproteome analyses revealed alterations to various signaling pathways in response to basal media differences. Overall, our results demonstrate that baseline culture conditions can have a profound influence on the performance of in vitro BBB models, and these effects should be considered when designing experiments that utilize such models for basic research and preclinical assays.

Indexed as

Blood-Brain BarrierCell DifferentiationCell Membrane PermeabilityCulture MediaCulture Media, Serum-FreeHumansInduced Pluripotent Stem CellsCulture MediaCulture Media, Serum-Freeblood-brain barrierbrain microvascular endothelial cellhuman-induced pluripotent stem cellin vitro model

Identifiers

PMID34716922
PMCPMC8688328

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.